A recent stock pick from the Investor Advisory Service newsletter has been featured on MoneyShow.com.

This stock from our IAS stock newsletter potentially offers a rare combination of traditional value, backed by sales of its approved drugs, and upside excitement thanks to its high-potential pipeline assets, and was one of the MoneyShow.com's stock picks of the day this week.

Read the complete article.